Mazdutide: A GLP-1/Glucagon Dual Agonist in Metabolic Research

Mazdutide is a dual GLP-1/glucagon receptor agonist peptide, structurally distinct from the single-target GLP-1 compounds that dominated early metabolic peptide research. By engaging both receptors, it is studied for a metabolic profile that goes beyond appetite suppression into direct effects on hepatic lipid handling and energy expenditure.

Mechanism of Action

Mazdutide activates two separate G-protein-coupled receptor systems simultaneously:

• ·GLP-1 receptor agonism — the same pathway targeted by Semaglutide and Tirzepatide, driving appetite suppression, delayed gastric emptying, and improved glucose-dependent insulin secretion
• ·Glucagon receptor agonism — a less common target in this compound class, associated in preclinical models with increased hepatic fatty acid oxidation and resting energy expenditure

This dual mechanism places Mazdutide conceptually between single-target GLP-1 agonists and the triple-agonist Retatrutide, which additionally engages the GIP receptor. Researchers studying receptor-selectivity questions often examine Mazdutide alongside Retatrutide research to isolate the contribution of glucagon signalling versus GIP signalling to fat mass reduction.

Research Findings

Early-phase trial data and preclinical modelling on Mazdutide have reported:

• ·Dose-dependent body weight reduction comparable to dual GIP/GLP-1 agonists at matched exposure
• ·Favourable changes in liver fat content, consistent with the glucagon receptor's role in hepatic lipid metabolism
• ·Improvements in fasting glucose and lipid panels in metabolic syndrome research models
• ·A tolerability profile similar to other incretin-class peptides, with GI-related effects the most commonly reported in early research

How It Differs From Semaglutide and Tirzepatide

| Compound | Receptor Targets |

|---|---|

| Semaglutide | GLP-1 (single) |

| Tirzepatide | GLP-1 + GIP (dual) |

| Mazdutide | GLP-1 + glucagon (dual) |

| Retatrutide | GLP-1 + GIP + glucagon (triple) |

The distinction matters for research design: glucagon receptor engagement is mechanistically tied to hepatic energy expenditure rather than purely appetite-mediated weight loss, making Mazdutide a useful comparator compound when isolating variables in metabolic pathway research.

Reconstitution and Handling

Mazdutide ships as a lyophilized powder and should be reconstituted with bacteriostatic water using standard aseptic technique. Store lyophilized vials at -20°C and reconstituted solution at 2–8°C, following the same handling protocol used across the GLP-1 research class — see the peptide reconstitution guide for volume calculations.

Shop Mazdutide or reference the Mazdutide dosage protocol for a structured research framework.

Note: Mazdutide is sold by JA Performance strictly for laboratory and in vitro research use. Not for human consumption.